tiprankstipranks
Trending News
More News >
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market

TransCode Therapeutics (RNAZ) Ownership - Who Owns TransCode Therapeutics?

Compare
413 Followers

TransCode Therapeutics (RNAZ) Ownership Overview

0.64%5.43%0.04%99.32%
0.64%
Insiders
5.43%
Mutual Funds
0.04% ETFs
99.32% Public Companies and Individual Investors
The ownership structure of TransCode Therapeutics (RNAZ) stock is a mix of institutional, retail, and individual investors. , 0.64% is owned by Insiders, and 99.32% is owned by Public Companies and Individual Investors.
The ownership structure of TransCode Therapeutics (RNAZ) stock is a mix of institutional, retail, and individual investors. Approximately 5.47% of the company’s stock is owned by Institutional Investors, 0.64% is owned by Insiders, and 99.32% is owned by Public Companies and Individual Investors.

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
56,318Insider6.76%459,555
9,381Institution1.13%76,549
4,679Institution0.56%38,181

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,679Institution0.56%38,181

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
9,381Institution1.13%3,814

FAQ

Who Owns TransCode Therapeutics (RNAZ)?
Currently, no data Available
What percentage of TransCode Therapeutics (RNAZ) stock is held by institutional investors?
Currently, no data Available
What percentage of TransCode Therapeutics (RNAZ) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.32% of TransCode Therapeutics (RNAZ) stock is held by retail investors.
    Who owns the most shares of TransCode Therapeutics (RNAZ)?
    Thomas A Fitzgerald owns the most shares of TransCode Therapeutics (RNAZ).
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis